Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472314 · ClinicalTrials.gov registry record · Phase 4
Exparel for Postoperative Pain Management in Shoulder Surgery
A Phase 4 study of Fracture of Shoulder and Upper Arm, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT02472314: Completed Phase 4 study of Fracture of Shoulder and Upper Arm, sponsored by Wayne State University.
NCT02472314 is a Phase 4 study of Fracture of Shoulder and Upper Arm that has completed, run by Wayne State University. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02472314, a Phase 4 study of Fracture of Shoulder and Upper Arm, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.
Primary Outcome
Quality of analgesia as measured by numerical rating scores for pain (active and at rest) as (0=no pain, 10= worst pain) every two hours for the initial 36 hours, then on day2, day7 and day30 postoperatively
Conditions Studied
Interventions
- DRUG 1.3% Liposomal Bupivacaine
- DRUG 0.125% Bupivacaine
Study Locations (1)
Michigan
- Wayne State University Physician Group - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
What the finished NCT02472314 record still lists
NCT02472314 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Fracture of Shoulder and Upper Arm appearing as the primary indexed condition, and to 2 interventions - of which 1.3% Liposomal Bupivacaine is the first listed.
NCT02472314 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02472314 about?
NCT02472314 is a clinical study titled "Exparel for Postoperative Pain Management in Shoulder Surgery". The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.
What is the current status of trial NCT02472314?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2015-06. Estimated completion is 2017-05.
What conditions does trial NCT02472314 study?
This clinical trial studies the following conditions: Fracture of Shoulder and Upper Arm.
What interventions are being tested in trial NCT02472314?
The interventions under investigation include: 1.3% Liposomal Bupivacaine (DRUG), 0.125% Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02472314?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02472314 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02472314's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia